It was a pleasure to participate in the IAmBIO podcast with Raffi Seyum and Jay Goodman at the 2024 BIO International Convention to share our perspective on how biotech breakthroughs converge with solutions for patients #BIO2024 #IamBIO #NeuroKaire #mentalhealthinnovation #precisionmedicine #personalizedhealth
NeuroKaire (formerly Genetika+)’s Post
More Relevant Posts
-
Join us on an important episode of BIO from the BAYOU! 🎙️ Discover the groundbreaking T-Vant, a revolutionary vaccine adjuvant developed by Tulane University's experts, Lisa Morici, PhD, and James McLachlan, PhD. Learn how T-Vant is set to transform the vaccine landscape. Don't miss insights on emerging innovations! 🌟 #VaccineInnovation #Biotech #TulaneUniversity #Podcast Link in comments ➡️
-
Listen here as Brandon Miller shares how #DEI is critical to make better decisions in the #lab in order to more authentically and accurately market to a diverse array of patients. And, read his key #insights from the conversation in this article: https://lnkd.in/em4RNiFG
The latest installment of the New Matter Accessibility in the Lab podcast series features Brandon Miller, Client Solutions Executive and Diversity Services Lead at Clarkston Consulting. This week’s discussion centers around diversity, equity and inclusion (DEI) issues in the lab and the life sciences industry and emphasizes how understanding diverse communities leads to better product development and marketing strategies. Milller explains how DEI practices, such as hiring diverse talent and fostering inclusive workplace cultures, directly impact the quality and success of life science products, from drug development to marketing campaigns. Listen now: https://lnkd.in/dpSVJdAK. Thank you to Roche for sponsoring this episode. Roche Sequencing USA is building on Roche’s legacy of innovation to transform next-generation sequencing and its application. By simplifying workflows and expanding assay menus, they are broadening access to genomic data and lowering barriers to routine use.
-
Delighted to unveil the newest #Biotech 2050 episode with Marshall Fordyce, M.D. Fordyce, the innovative Founder & CEO of Vera Therapeutics, Inc.! 🎙️ In this episode, Host Rahul Chaturvedi joins Marshall as they delve into his transformative journey from physician to biotech entrepreneur, offering invaluable perspectives on the biotech industry. Discover how Vera Therapeutics pivoted to focus on IG nephropathy and their groundbreaking work with atacicept, a promising B-cell modulator. Key highlights include: 🔹 The importance of scientific rigor and adaptability 🔹 Navigating the biotech landscape 🔹 Future outlook on autoimmune disease treatments Whether you're an aspiring entrepreneur or a seasoned professional, Marshall's insights on maintaining a lean operating model and driving innovation are a must-listen. 🎧 Tune in now and get inspired by the future of autoimmune disease treatments: https://lnkd.in/eaq7isNN #Biotech #Autoimmune #Innovation #Healthcare #BiotechBreakthroughs #Podcast #MedicalResearch #ClinicalTrials #DrugDevelopment #HealthcareInnovation #Entrepreneurship
-
Episode 7 of the GxPodcast is live, have you tuned in yet? 🎙️ In this episode, we talk about the power of process and how this can help teams to overcome challenges and ensure they are avoided in future work. Follow the link below to hear Chris Lewis of Umoja Biopharma talk about how he has seen processes implemented in the life science industry. 🔗 https://lnkd.in/exW4jkBB #GxPodcast #iPharmGxP
-
🚀 New Episode Alert! 🚀 Tune in to Episode 41 of BIO from the BAYOU: "BIO 2024 Highlights - Key Takeaways + Trends in Biotech." Hosts James Zanewicz, JD, LLM, RTTP, and Elaine Hamm, PhD, recap their experiences from the BIO International Convention in San Diego. Discover insights on women's health, the rapid adoption of AI in healthcare, and successful side events like the Bullpen and Ticket to Biotech. Don't miss out on their reflections on productive partnering sessions and the future of the biotech industry. 🔗 Link in comments! #Biotech #HealthcareInnovation #AIinHealthcare #BIO2024 #WomensHealth
-
Did you catch the lastest episode of Matthew Pillar's Business of Biotech? Matt chats with the CEO of Intellia Therapeutics, Inc., John Leonard about building a #biotech hub. Listen to the #podcast here: https://lnkd.in/gykmwPuA #podcast #CRISPR #emergingbiotech
-
Integrated Solutions Strategy Director | Clinical Delivery Solutions for Biotech and Pharma | MBA Clinical Research Management
Newest episode from stats biotech news
The Readout Loud: 306: Live! From the STAT Breakthrough Summit West op Apple Podcasts
podcasts.apple.com
-
Are you joining us for this roundtable discussion at #ISCT2024 next week on how to better integrate sustainable processes into #cellandgenetherapy applications?
🗣 Announcing our Roundtable Session at #ISCT2024! Moderated by our Vice President of Strategy Quentin VICARD, we will be discussing on how to integrate environmentally conscious processes and decisions in the #cellandgenetherapy field. It´s a huge honour for us to count with the participation of key leaders in the space, including: 🙌 Asma Ayari, Ph.D., R&D Director from our wonderful collaborators at Nucleus Biologics 🧫 The highly regarded expert in CAR-T for solid tumors, Roddy O'Connor, Ph.D. form University of Pennsylvania 🚀 And the Global Director of Commercial Operations Josh Ludwig from the innovative company focused on simplifying cell therapies to achieve robust automation and scalability, ScaleReady As we see the cell and gene therapy industry adopting sustainable practices to reduce its environmental impact, we need to improve on using renewable energy, cutting waste, and recycling. These efforts support global environmental goals, enhance the industry's reputation, and ensure long-term viability while promoting therapeutic innovation. At Core Biogenesis we enable manufacturers to reduce costs and achieve their sustainability goals by supplying raw materials with lower carbon footprint, thanks to our plant-derived recombinant proteins 💚 Join us in this wonderful discussion at the ISCT, International Society for Cell & Gene Therapy Vancouver on May 31st at 5pm 🗓 Don´t miss this! #ISCT2024 #cellandgenetherapy #sustainability #rawmaterials
-
-
Co-Founder, CEO & Chief Scientific Officer, Genzeva, LumaGene; Johns Hopkins University School of Medicine, Genetics, and MIT, Artificial Intelligence, Biomimetic Digital Twins
My heartfelt gratitude to the 51 Pharma and Biotech companies, as well as the National Institutes of Health (NIH), for engaging in insightful discussions during the One-on-One Partnering Program at BIO2024. Their keen interest in our Multiomics and Biomimetic Digital Twin Ecosystem analysis is truly inspiring, underscoring the importance of collaborative innovation in the healthcare industry. Through the publication of peer-reviewed papers, we have showcased the transformative impact of our work: - Enhanced pathophysiology understanding of diseases - Commencement of reclassification of variants of unknown clinical significance (VUSs) - Potential reduction in drug development time and costs by approximately 25-35% A significant milestone in our journey is the establishment of a partnership with the NIH for groundbreaking research on rare diseases. Looking forward to continued collaboration and advancements in healthcare that benefit patients worldwide. #Biotech #Pharma #HealthcareInnovation #Collaboration #Research #BIO2024
-
The future of medicine is here, and it's personalized! Join us on the SciMed Biotech Podcast as we sit down with Rafael Rosengarten, CEO of Genialis, to explore the revolutionary world of precision medicine. In this engaging episode, we uncover: 📊 How Genialis is using high-dimensional data to reshape drug development. 💡 The power of RNA-based biomarkers for more targeted treatments. 🌱 The People First philosophy driving innovation in healthcare. Get inspired and stay ahead in the biotech field! Tune in to the podcast now. #SciMedPodcast #biotech #medicine
SciMed Biotech Podcast with Rafael Rosengarten of Genialis — SciMed
scimed.io
